300239
vs
S
Shanghai Composite
300239
Over the past 12 months, Baotou Dongbao Bio-Tech Co Ltd has underperformed Shanghai Composite, delivering a return of +11% compared to the Shanghai Composite's +22% growth.
Stocks Performance
300239 vs Shanghai Composite
Performance Gap
300239 vs Shanghai Composite
Performance By Year
300239 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Baotou Dongbao Bio-Tech Co Ltd
Glance View
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, design, production, and sales of gelatin, collagen, and calcium hydrogen phosphate. The company is headquartered in Baotou, Neimenggu and currently employs 1,354 full-time employees. The company went IPO on 2011-07-06. The firm primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The firm distributes its products in both domestic and overseas markets, with domestic markets as its major markets.
